{"product_id":"hd-labs-retatrutide-32mg-pen","title":"HD Labs Retatrutide 32mg Pen","description":"\u003cp data-end=\"617\" data-start=\"379\"\u003eRetatrutide is a peptide currently under advanced clinical investigation for its activity across multiple metabolic pathways. It is designed to act on\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"614\" data-start=\"549\"\u003ethree key receptors involved in glucose and energy regulation\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cul data-end=\"731\" data-start=\"618\"\u003e\n\u003cli data-end=\"653\" data-start=\"618\"\u003e\n\u003cp data-end=\"653\" data-start=\"620\"\u003eGLP-1 (glucagon-like peptide-1)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"708\" data-start=\"654\"\u003e\n\u003cp data-end=\"708\" data-start=\"656\"\u003eGIP (glucose-dependent insulinotropic polypeptide)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"731\" data-start=\"709\"\u003e\n\u003cp data-end=\"731\" data-start=\"711\"\u003eGlucagon receptors\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"927\" data-start=\"733\"\u003eThrough this\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"774\" data-start=\"746\"\u003etriple-agonist mechanism\u003c\/strong\u003e, retatrutide has been studied for its effects on insulin secretion, regulation of glucose production, gastric emptying, and appetite-related signalling.\u003c\/p\u003e\n\u003chr data-end=\"932\" data-start=\"929\"\u003e\n\u003ch3 data-end=\"959\" data-start=\"934\"\u003eClinical Trial Status\u003c\/h3\u003e\n\u003cp data-end=\"1077\" data-start=\"960\"\u003eAs of\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"974\" data-start=\"966\"\u003e2025\u003c\/strong\u003e, retatrutide remains\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"1052\" data-start=\"996\"\u003eunder investigation and is not yet formally approved\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003efor general medical use.\u003c\/p\u003e\n\u003cul data-end=\"1534\" data-start=\"1079\"\u003e\n\u003cli data-end=\"1280\" data-start=\"1079\"\u003e\n\u003cp data-end=\"1280\" data-start=\"1081\"\u003e\u003cstrong data-end=\"1109\" data-start=\"1081\"\u003ePhase 2 clinical studies\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003ereported significant outcomes, with participants experiencing an\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"1245\" data-start=\"1175\"\u003eaverage body-weight reduction of approximately 24.2% over 48 weeks\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eunder controlled trial conditions.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1534\" data-start=\"1281\"\u003e\n\u003cp data-end=\"1534\" data-start=\"1283\"\u003e\u003cstrong data-end=\"1310\" data-start=\"1283\"\u003ePhase 3 clinical trials\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eare ongoing and have reported\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"1422\" data-start=\"1341\"\u003econtinued, clinically meaningful effects consistent with earlier trial phases\u003c\/strong\u003e, further evaluating long-term safety, efficacy, and tolerability. Final data and regulatory review are pending.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"1617\" data-start=\"1536\"\u003eNo guarantees of outcome can be inferred outside of controlled clinical settings.\u003c\/p\u003e\n\u003chr data-end=\"1622\" data-start=\"1619\"\u003e\n\u003ch3 data-end=\"1652\" data-start=\"1624\"\u003eHow Retatrutide Compares\u003c\/h3\u003e\n\u003cp data-end=\"1725\" data-start=\"1653\"\u003eRetatrutide is often discussed alongside other incretin-based compounds:\u003c\/p\u003e\n\u003cul data-end=\"2050\" data-start=\"1727\"\u003e\n\u003cli data-end=\"1791\" data-start=\"1727\"\u003e\n\u003cp data-end=\"1791\" data-start=\"1729\"\u003e\u003cstrong data-end=\"1744\" data-start=\"1729\"\u003eSemaglutide\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eacts primarily as a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"1791\" data-start=\"1765\"\u003eGLP-1 receptor agonist\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1875\" data-start=\"1792\"\u003e\n\u003cp data-end=\"1875\" data-start=\"1794\"\u003e\u003cstrong data-end=\"1809\" data-start=\"1794\"\u003eTirzepatide\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"1831\" data-start=\"1815\"\u003edual agonist\u003c\/strong\u003e, targeting both\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"1875\" data-start=\"1848\"\u003eGLP-1 and GIP receptors\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2050\" data-start=\"1876\"\u003e\n\u003cp data-end=\"2050\" data-start=\"1878\"\u003e\u003cstrong data-end=\"1893\" data-start=\"1878\"\u003eRetatrutide\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"1917\" data-start=\"1899\"\u003etriple agonist\u003c\/strong\u003e, additionally engaging the\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"1966\" data-start=\"1945\"\u003eglucagon receptor\u003c\/strong\u003e, which differentiates its investigational profile from earlier-generation compounds\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"2055\" data-start=\"2052\"\u003e\n\u003ch3 data-end=\"2082\" data-start=\"2057\"\u003eImportant Information\u003c\/h3\u003e\n\u003cul data-end=\"2441\" data-start=\"2083\"\u003e\n\u003cli data-end=\"2145\" data-start=\"2083\"\u003e\n\u003cp data-end=\"2145\" data-start=\"2085\"\u003eThis product is supplied in a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2145\" data-start=\"2115\"\u003epre-mixed pen format\u003c\/strong\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2265\" data-start=\"2212\"\u003e\n\u003cp data-end=\"2265\" data-start=\"2214\"\u003eRetatrutide remains an\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2265\" data-start=\"2237\"\u003einvestigational compound\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2367\" data-start=\"2266\"\u003e\n\u003cp data-end=\"2367\" data-start=\"2268\"\u003eConsultation with a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2320\" data-start=\"2288\"\u003elicensed healthcare provider\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis essential prior to any consideration of use\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2441\" data-start=\"2368\"\u003e\n\u003cp data-end=\"2441\" data-start=\"2370\"\u003eResults observed in clinical trials may not reflect real-world outcomes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"2446\" data-start=\"2443\"\u003e\n\u003ch3 data-end=\"2481\" data-start=\"2448\"\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003cp data-end=\"2588\" data-start=\"2482\"\u003eThis product is supplied strictly on an\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2550\" data-start=\"2522\"\u003einformed purchaser basis\u003c\/strong\u003e. By purchasing, you acknowledge that:\u003c\/p\u003e\n\u003cul data-end=\"3029\" data-start=\"2590\"\u003e\n\u003cli data-end=\"2671\" data-start=\"2590\"\u003e\n\u003cp data-end=\"2671\" data-start=\"2592\"\u003eYou have independently researched this product and its investigational status\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2748\" data-start=\"2672\"\u003e\n\u003cp data-end=\"2748\" data-start=\"2674\"\u003eYou have consulted, or will consult, a qualified healthcare professional\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2859\" data-start=\"2749\"\u003e\n\u003cp data-end=\"2859\" data-start=\"2751\"\u003eYou understand that retatrutide is\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2806\" data-start=\"2786\"\u003enot yet approved\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eand remains subject to ongoing clinical evaluation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2943\" data-start=\"2860\"\u003e\n\u003cp data-end=\"2943\" data-start=\"2862\"\u003eThe seller provides\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2941\" data-start=\"2882\"\u003eno medical advice, treatment claims, or dosing guidance\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3029\" data-start=\"2944\"\u003e\n\u003cp data-end=\"3029\" data-start=\"2946\"\u003eThe\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"3029\" data-start=\"2950\"\u003eonus of lawful, safe, and appropriate use rests entirely with the purchaser\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Vitality Lab","offers":[{"title":"Default Title","offer_id":43251196133489,"sku":null,"price":2100.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0681\/2457\/3809\/files\/Screenshot2026-05-18130123.png?v=1779101986","url":"https:\/\/vitalitylab.co.za\/products\/hd-labs-retatrutide-32mg-pen","provider":"Vitality Lab","version":"1.0","type":"link"}